IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.

IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.
复制标题

DOI:
10.1002/ijc.24623
复制
发表时间:
2009-12-01
影响因子:
6.4
通讯作者:
Gammon, Marilie D.
Gammon, Marilie D.
中科院分区:
医学1区
文献类型:
--
作者:
Hoyo, Cathrine;Schildkraut, Joellen M.;Murphy, Susan K.;Chow, Wong-Ho;Vaughan, Thomas L.;Risch, Harvey;Marks, Jeffrey R.;Jirtle, Randy L.;Calingeart, Brian;Mayne, Susan;Fraumeni, Joseph, Jr.;Gammon, Marilie D.

文献摘要

参考文献

被引文献

相似文献

甘露糖6磷酸/胰岛素样生长因子2受体(M6 P/IGF 2 R)编码的蛋白质在肿瘤抑制中起关键作用,部分通过调节强效促分裂剂胰岛素样生长因子-2(IGF 2)的生物利用度。我们检验了M6 P/IGF 2 R外显子6的c.901 C>G(Leu>瓦尔)和外显子34的c.5002 G>A(Gly>Arg)中常见的非同义遗传变异与食管癌和胃癌风险相关的假设。这项基于人群的研究的研究参与者包括197名对照和182名病例,其中包括105名食管贲门腺癌(EGA),57名非贲门胃腺癌和20名食管鳞状细胞癌(ES)。在白色男性中,EGA(OR= 1.9; 95%CI=1.0-3.6)和非贲门胃癌(OR=2.5; 95%CI =1.2-5.5)与携带至少一个c.901 C>G等位基因相关的优势比(OR)升高,但与ES无关。探索性亚组分析表明,EGA与该变异体之间的关联在非甾体类抗炎药(NSAID)的不规则或非使用者(OR=2.3; 95%CI=1.2-4.2)和吸烟者(OR=2.1; 95%CI=1.0-4.2)中更强。携带c.5002G>A基因型与EGA之间的关联不明显。这些结果表明,M6 P/IGF 2 R的非同义多态性可能有助于EGA和非贲门腺癌的风险。需要更大规模的研究来证实这些发现。
The mannose 6 phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) encodes a protein that plays a critical role in tumor suppression, in part by modulating bioavailability of a potent mitogen, insulin-like growth factor-2 (IGF2). We tested the hypothesis that the common non-synonymous genetic variants in M6P/IGF2R c.901C>G (Leu>Val) in exon 6 and c.5002G>A (Gly>Arg) in exon 34 are associated with risk of esophageal and gastric cancers. Study participants in this population-based study comprise 197 controls and 182 cases, including 105 with esophageal-gastric cardia adenocarcinoma (EGA), 57 with non-cardia gastric adenocarcinoma and 20 with esophageal squamous cell carcinoma (ES). Among white males, odds ratios (ORs) were elevated in relation to carrying at least one c.901C>G allele for EGA (OR= 1.9; 95%CI=1.0–3.6) and non-cardia gastric cancer (OR=2.5; 95%CI=1.2–5.5), but not ES. Exploratory subgroup analyses suggested that associations between EGA and this variant were stronger among irregular or non-users of non-steroidal anti-inflammatory drugs (NSAIDs) (OR=2.3; 95%CI=1.2–4.2) and cigarette smokers (OR=2.1; 95%CI=1.0–4.2). An association between carrying the c.5002G>A genotype and EGA was not evident. These findings suggest that non-synonymous polymorphisms in M6P/IGF2R may contribute to the risks of EGA and non-cardia adenocarcinomas. Larger studies are required to confirm these findings.
DOI: 10.1111/j.1651-2227.2006.00120.x
发表时间: 2007-03-01
期刊: ACTA PAEDIATRICA
影响因子: 3.8
作者:
Kaku, K.;Osada, H.;Sekiya, S.
通讯作者: Sekiya, S.
DOI: 10.1210/en.2002-220751
发表时间: 2003-03-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
Schaffer, BS;Lin, MF;MacDonald, RG
通讯作者: MacDonald, RG
DOI: 10.1001/jama.289.1.76
发表时间: 2003-01-01
影响因子: 120.7
作者:
Mokdad, AH;Ford, ES;Marks, JS
通讯作者: Marks, JS
DOI: 10.1093/jnci/89.17.1277
发表时间: 1997-09-03
影响因子: 10.3
作者:
Gammon, MD;Schoenberg, JB;Fraumeni, JF
通讯作者: Fraumeni, JF
DOI: 10.1016/j.ejca.2005.12.024
发表时间: 2006-05-01
影响因子: 8.4
作者:
Ryan, Aoife M.;Rowley, Suzanne P.;Reynolds, John V.
通讯作者: Reynolds, John V.